Scientific Committee

Dr. Olivier Elemento is a leading computational biologist and Director of the Englander Institute for Precision Medicine at Weill Cornell Medicine. He earned his PhD in computational biology from the University of Montpellier in France. He completed his postdoctoral training at Princeton University. His research focuses on using artificial intelligence, genomics, and big data to improve the diagnosis and treatment of diseases. Dr. Elemento has applied precision medicine approaches to cancer, heart disease, and neurological disorders. He has received several awards, including the NSF CAREER Award. He also advises biotech companies and helps translate scientific discoveries into clinical applications.

Florian Markowetz is a Professor of Computational Oncology at the University of Cambridge and Senior Group Leader at the Cancer Research UK Cambridge Institute. He is known for his pioneering work in cancer genomics, particularly in understanding chromosomal instability and its role in therapy resistance. With a background in mathematics and philosophy from Heidelberg University and a PhD in computational biology from Berlin, he has combined machine learning with cancer research to develop clinically relevant genomic signatures. His postdoctoral training was at Princeton University. Markowetz is also the co-founder of Tailor Bio, a precision oncology company translating research into patient care. He has received several honors, including the CRUK Future Leaders Prize and an ERC Advanced Grant. His research focuses on making precision medicine more predictive and impactful in real-world cancer treatment.

Dr. Yves A. Lussier is a physician-scientist specializing in precision medicine, translational bioinformatics, and personal genomics. He earned both his medical degree and engineering degree from the University of Sherbrooke in Canada. He co-founded Purkinje Incorporated, a company that developed early electronic medical records and pen-computing tools for doctors. He has held academic and leadership positions at Columbia University, the University of Chicago, the University of Illinois at Chicago, the University of Arizona, and the University of Utah. His research focuses on using big data, network modeling, and biomedical ontologies to personalize treatments and identify new uses for existing drugs. Dr. Lussier has published over 150 scientific papers and frequently speaks at international conferences. He has received several honors, including the IBM Faculty Award and Fellowship in the American College of Medical Informatics.

Dr. Vinod Scaria is an Indian clinician-scientist known for his contributions to genomics and precision medicine. He earned his medical degree from Calicut Medical College and completed his PhD in genomics. He is a senior scientist at the CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB) in New Delhi. His research focuses on human genome variation, rare genetic diseases, and the use of genomics in public health. He played a key role in sequencing the first Indian genome and has worked extensively on the genomics of rare and undiagnosed diseases. Dr. Scaria has published numerous scientific papers and is actively involved in science communication. He is also recognized for developing open-access platforms to promote genomic literacy and collaboration.

Hank Greely is a professor of law and a leading expert in the ethical, legal, and social implications of new biomedical technologies. He teaches at Stanford University, where he directs the Center for Law and the Biosciences. He holds a law degree from Yale and a bachelor's degree from Stanford. His work focuses on topics such as genetics, neuroscience, stem cell research, and human enhancement. He is widely known for his analysis of how advances in science impact law, ethics, and public policy. Professor Greely has published extensively and is a frequent speaker at international conferences. He also advises government and scientific bodies on bioethics and policy development.

Committee Members

Eimear Kenny

olivier elemento

Florian Markowetz

Yves A. Lussier

Vinod Scaria

Henry Greely